Xueli Bai

8.6k total citations
154 papers, 4.2k citations indexed

About

Xueli Bai is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Xueli Bai has authored 154 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 41 papers in Molecular Biology and 35 papers in Surgery. Recurrent topics in Xueli Bai's work include Pancreatic and Hepatic Oncology Research (43 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Organ Transplantation Techniques and Outcomes (16 papers). Xueli Bai is often cited by papers focused on Pancreatic and Hepatic Oncology Research (43 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Organ Transplantation Techniques and Outcomes (16 papers). Xueli Bai collaborates with scholars based in China, United States and Madagascar. Xueli Bai's co-authors include Tingbo Liang, Wei Chen, Qihan Fu, Yu Lou, Qida Hu, Tao Ma, Tingbo Liang, Chao Liang, Tingbo Liang and Xiaozhen Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Xueli Bai

142 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueli Bai China 37 1.8k 1.5k 1.2k 825 540 154 4.2k
Zhen‐Bin Ding China 36 1.9k 1.0× 1.3k 0.9× 1.1k 1.0× 806 1.0× 570 1.1× 89 4.1k
Xiaoying Wang China 34 1.6k 0.9× 1.7k 1.2× 890 0.8× 1.5k 1.8× 638 1.2× 88 4.6k
Ning Ren China 36 1.8k 1.0× 985 0.7× 1.5k 1.3× 443 0.5× 707 1.3× 113 3.7k
Runqiu Jiang China 33 2.3k 1.3× 1.0k 0.7× 1.7k 1.5× 886 1.1× 500 0.9× 61 4.3k
Zhi Dai China 38 2.7k 1.5× 1.7k 1.1× 1.9k 1.7× 1.3k 1.6× 677 1.3× 97 5.4k
Xiaowu Huang China 35 2.2k 1.2× 1.5k 1.0× 1.7k 1.5× 1.2k 1.5× 973 1.8× 112 4.8k
Limin Xia China 39 2.8k 1.5× 1.0k 0.7× 1.4k 1.2× 594 0.7× 240 0.4× 142 4.1k
Bo Zhai China 37 3.1k 1.7× 1.3k 0.9× 1.4k 1.2× 503 0.6× 889 1.6× 152 5.4k
Kai Breuhahn Germany 41 3.1k 1.7× 1.0k 0.7× 1.4k 1.2× 577 0.7× 540 1.0× 128 5.2k
ST Cheung Hong Kong 38 2.7k 1.5× 1.6k 1.1× 1.2k 1.0× 443 0.5× 929 1.7× 86 4.9k

Countries citing papers authored by Xueli Bai

Since Specialization
Citations

This map shows the geographic impact of Xueli Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueli Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueli Bai more than expected).

Fields of papers citing papers by Xueli Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueli Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueli Bai. The network helps show where Xueli Bai may publish in the future.

Co-authorship network of co-authors of Xueli Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Xueli Bai. A scholar is included among the top collaborators of Xueli Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueli Bai. Xueli Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Xueli, Yuqi Zhang, Xueying Zhang, et al.. (2025). Synergistic anti-oxidative/anti-inflammatory treatment for acute lung injury with selenium based chlorogenic acid nanoparticles through modulating Mapk8ip1/MAPK and Itga2b/PI3k-AKT axis. Journal of Nanobiotechnology. 23(1). 37–37. 10 indexed citations
2.
Liu, Xinyuan, Jiaqi Yang, Sicong Huang, et al.. (2025). Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRASG12D protein to cancer-associated fibroblasts. Molecular Therapy. 33(3). 1134–1153. 5 indexed citations
3.
Lin, Yi, et al.. (2025). Harnessing amino acid pathways to influence myeloid cell function in tumor immunity. Molecular Medicine. 31(1). 44–44. 3 indexed citations
4.
Lao, Mengyi, Xiaozhen Zhang, Zejun Li, et al.. (2025). Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy. Cancer Communications. 45(8). 1010–1037. 1 indexed citations
5.
Yang, Jing, Qin Xue, Xing Chen, et al.. (2024). Triglyceride-glucose index and health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies. Cardiovascular Diabetology. 23(1). 177–177. 35 indexed citations
6.
Wang, Yangyang, Yuntao Zhang, Wei Dong Zhang, et al.. (2024). Universal antifungal prophylaxis effectively prevents fungal bloodstream infection in pediatric liver transplant recipients: a retrospective real-world study. International Journal of Infectious Diseases. 143. 107003–107003.
7.
Chen, Yiwen, Wendi Hu, Xiang Li, et al.. (2024). Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study. Signal Transduction and Targeted Therapy. 9(1). 280–280. 6 indexed citations
8.
9.
10.
Sheng, Jianpeng, Qi Zhang, Xun Wang, et al.. (2023). Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability. Journal for ImmunoTherapy of Cancer. 11(2). e006119–e006119. 19 indexed citations
11.
Hu, Peijun, Xiang Li, Na Lu, et al.. (2023). Prediction of New-Onset Diabetes After Pancreatectomy With Subspace Clustering Based Multi-View Feature Selection. IEEE Journal of Biomedical and Health Informatics. 27(3). 1588–1599. 9 indexed citations
12.
He, Lihong, et al.. (2023). Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer. Cancers. 15(8). 2225–2225. 3 indexed citations
13.
Sheng, Jianpeng, Qi Chen, Johannes U. Mayer, et al.. (2021). Fate mapping analysis reveals a novel murine dermal migratory Langerhans-like cell population. eLife. 10. 19 indexed citations
14.
Hu, Peijun, Xiang Li, Yu Tian, et al.. (2020). Automatic Pancreas Segmentation in CT Images With Distance-Based Saliency-Aware DenseASPP Network. IEEE Journal of Biomedical and Health Informatics. 25(5). 1601–1611. 46 indexed citations
15.
Wei, Tao, Qi Zhang, Xiang Li, et al.. (2018). Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer. Molecular Cancer Therapeutics. 18(1). 196–203. 70 indexed citations
16.
Zhang, Qi, Yu Lou, Jingying Zhang, et al.. (2017). Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer. Molecular Cancer. 16(1). 119–119. 99 indexed citations
17.
Ye, Long‐Yun, Wei Chen, Xueli Bai, et al.. (2016). Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis. Cancer Research. 76(4). 818–830. 233 indexed citations
18.
Bai, Xueli, Qi Zhang, Long‐Yun Ye, et al.. (2014). Inhibition of Protein Phosphatase 2A Enhances Cytotoxicity and Accessibility of Chemotherapeutic Drugs to Hepatocellular Carcinomas. Molecular Cancer Therapeutics. 13(8). 2062–2072. 31 indexed citations
19.
Zhang, Qi, Xueli Bai, Wei Chen, et al.. (2013). Wnt/β-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Carcinogenesis. 34(5). 962–973. 203 indexed citations
20.
Chen, Wei, Tao Ma, Xuning Shen, et al.. (2012). Macrophage-Induced Tumor Angiogenesis Is Regulated by the TSC2–mTOR Pathway. Cancer Research. 72(6). 1363–1372. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhen‐Bin Ding Breakdown of academic impact, for papers by Xiaoying Wang Breakdown of academic impact, for papers by Ning Ren Breakdown of academic impact, for papers by Runqiu Jiang Breakdown of academic impact, for papers by Zhi Dai Breakdown of academic impact, for papers by Xiaowu Huang Breakdown of academic impact, for papers by Limin Xia Breakdown of academic impact, for papers by Bo Zhai Breakdown of academic impact, for papers by Kai Breuhahn Breakdown of academic impact, for papers by ST Cheung
Rankless by CCL
2026